ADPHC, AstraZeneca forge strategic partnership to enhance COPD awareness, care in Abu Dhabi
14 May 2025 00:05
ABU DHABI (WAM)The Abu Dhabi Public Health Centre (ADPHC) and AstraZeneca FZ LLC (AstraZeneca) have signed a Memorandum of Understanding (MoU) to launch a collaborative public health project to strengthen public health initiatives, and improve outcomes for patients with chronic obstructive pulmonary disease (COPD) in Abu Dhabi emirate.
The MoU was signed on May 13 2025, by Dr. Omniyat Al Hajeri, Executive Director of Community Health sector, representing ADPHC, and Sameh El Fangary. Cluster President GCC, AstraZeneca, representing global biopharmaceutical AstraZeneca, during the 25th IUHPE World Conference on Health Promotion, taking place from May 13 to 16, 2025, at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Rashed Alsuwaidi, Director General of ADPHC said, "This partnership reflects our steadfast commitment to improving population health in Abu Dhabi through proactive and innovative approaches. By partnering with AstraZeneca, we aim to deliver comprehensive solutions that raise public awareness, promote early screening, and enable best-in-class care for COPD patients. This initiative builds upon the recommendations from the Abu Dhabi Public Health System Sustainability and Resilience (PHSSR) report and strengthens our vision of a healthier Abu Dhabi."Sameh El Fangary, Cluster President GCC, AstraZeneca shared, "Our most recent collaboration with ADPHC is a significant milestone in advancing public health and addressing the rising burden of chronic respiratory diseases in the UAE. Through this MoU, we are proud to support the UAE's healthcare priorities by sharing global best practices, driving education, and enabling early diagnosis and treatment pathways. Together, we are working towards a future where every patient has the opportunity to achieve better health outcomes and an improved quality of life."The strategic agreement outlines a shared vision between ADPHC and AstraZeneca to enhance population health through coordinated efforts centred around disease awareness, prevention, and best practice sharing. This shared vision will significantly benefit COPD patients in Abu Dhabi.The two-year partnership aligns with the company's mission to transform healthcare, and improve patient outcomes, through evidence-based and collaborative approaches.The strategic alliance focuses on three key pillars:-Disease Awareness: Jointly creating and executing public awareness campaigns to educate the community about COPD. This will include online and offline initiatives to encourage routine testing and early screening.-Disease Prevention: Developing early detection strategies to identify COPD in its initial stages, enabling timely intervention and management to reduce the long-term health burden on individuals and the healthcare system.-Best Practice Sharing: Utilising AstraZeneca's global insights and best practices in diagnostics and disease management to enhance patient care in Abu Dhabi. This may include workshops, knowledge exchange sessions with other AstraZeneca affiliates, and collaboration with international partners.A joint task force will be established, with ADPHC and AstraZeneca representatives to oversee the project's execution. The task force will be responsible for aligning strategic priorities, evaluating feasibility, and tracking the progress of each initiative under the Mou. All agreed-upon projects will be subject to further detailed documentation, and the implementation will proceed upon mutual approval from both parties' leadership.ADPHC, which is dedicated to elevating community health through innovation and integrated public health systems, continues to build on its commitment to address non-communicable diseases, including cancer and respiratory illnesses. As part of its broader public health strategy, ADPHC launched the Abu Dhabi Public Health Sustainability and Resilience (PHSSR) report, emphasising the need for early screening and legislative support to combat chronic diseases.AstraZeneca, a global leader in addressing non-communicable diseases (NCDs) in oncology, cardiovascular, renal, and metabolic diseases (CVRM), respiratory conditions such as COPD, and rare diseases, brings unparalleled expertise to the collaboration.
This partnership is a testament to the unwavering commitment of both ADPHC and AstraZeneca to improving public health in Abu Dhabi, and advancing innovative solutions for chronic disease management.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
3 days ago
- The National
A cancer crisis is inevitable. What can we do about it?
The number of cancer patients is set to rise dramatically throughout the entire Gulf region. This is simply because of changes in the age of its population. Cancer can, of course, occur at any age but it predominantly occurs in older people. In the UK, 25 per cent of the population is now over 60 compared to only 3.6 per cent in the UAE. The number of new cancer patients in this region per million people is currently less than half that in Europe. But this is set to change rapidly with a much more European age pattern coming to all GCC countries. The risk factors for cancer due to age are already locked-in, so a health crisis is inevitable. There will be a significant rise in both incidence (the number of new cases) and prevalence (the number of patients living with cancer). The World Health Organisation predicts a more than doubling of both in the GCC region by 2050. The 'big four' cancers are those arising in breast, colon, lung and prostate, which make up 65 per cent of diagnoses. Each cancer has its own age profile and causation. As breast cancer starts rising in women in their forties, it is unsurprising that we are already seeing a huge increase. The other types will surely follow in the next decade. But a real puzzle is emerging. Over the past 20 years, we have seen a dramatic increase of certain cancers in the 30-50 age group globally. This trend started in the 1990s, so has nothing to do with Covid-19 or its vaccines. Lymphoma, melanoma, head and neck as well as the big four cancers are all involved. What is going on and what can we do about it? We know that age is the biggest risk factor and we just cannot stop the clock. But changing lifestyles are definitely involved too. The interplay of diet, exercise and obesity can alter the hormonal balance in the body. How we work, play and relax now is different from the past. Only three generations ago, the Gulf was a land of nomadic tribesmen with a healthy lifestyle. Subsequent generations now sit in smart high-rise offices, often with sedentary lifestyles and a diet heavy with processed food. But why is this increasing the risk of cancer? Our lifestyle contributes to the composition of the microbiome – the bugs that colonise our intestines breaking down potential carcinogens and toxins. Powerful data-mining artificial intelligence programmes are being used to study the huge number of variables involved. Within five years, it is likely we will understand more clearly the factors causing defects in cell growth control that allow rogue cells to emerge. These become the enemy within – the cancer. Greater understanding will allow specific tailored cancer prevention advice to individuals. Prevention and screening messages are always far more powerful if individualised. Risk-based screening for common cancers will be revolutionised by multi-cancer early detection tests, or MCEDs. These pick up abnormal DNA fragments released by tiny early cancers which circulate in the blood. Although there are several on the market, they produce too high a false positive rate to be used on everyone. They can make the worried well even more worried. Eventually, a reliable, self-administered finger prick sample will be enough to diagnose cancer accurately, but we're just not there yet. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease Technology will allow us to diagnose cancer in its very early stages where outcomes are best. The Gulf is well provided with increasingly sensitive diagnostic scanners, both MRI and CT. And molecular analysis of biopsies from cancers will provide far more personalised individual drug and radiation combinations. The future physicians' laptop will not only choose the optimal therapy but also predict probable unpleasant side effects. AI will be used extensively to understand individual interactions to treatments – both good and bad allowing perfect personalisation. The Gulf has many excellent cancer treatment facilities. But there are few effective networks allowing the combination of international expertise bringing multi-disciplinary opinions for patients and yet delivering care close to their homes currently in place. Treating cancer effectively is no quick fix, often taking several months of frequent hospital visits for radiotherapy and chemotherapy. The medical tourism model used for elective surgery is not feasible. The increasing cost of optimal cancer care is driving government health bodies globally to reduce the wide inconsistencies in treatment protocols. Networked care from a mixed economy of public and private providers is very much the future. It allows the development of a financially sustainable model adapted to a country's overall wealth. Increasing financial investment into an individuals' cancer care obviously increases the benefit to the patient. But there is a limit – a therapeutic plateau – where further spending brings no benefit for the patient. Poorer countries such as those of middle Africa operate well below it; most of Europe and Asia is comfortably at its beginning but the US is far along it, spending vast sums of money for no gain in the last few months of a patients' life. Networked care is the solution to providing the best individual treatment and yet minimising its toxicity both for the patient and financially for the payor. Coupling the intellectual power of a large central university hospital with skilled technical care close to home is what families want. Currently we cure over 90 per cent of patients with early-stage cancer. When the disease has spread outside its organ of origin, this figure drops dramatically. So, the emphasis has to be on streamlining the diagnostic phase and fast-tracking treatment. The current emphasis is very much on maintaining the best quality of life both during and after therapy. We are now far more honest with our patients and try to manage their expectations with frankness. Breakthroughs appear in the media regularly driven by commercial interests from biotech and pharma companies and their investors. Their hyped-up message can often raise false hope. Public education and better screening lead to earlier diagnosis and better outcomes. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease.
Zawya
3 days ago
- Zawya
Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions. Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region. Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects. 'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the region.' Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships. 'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care. On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks. In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs. 'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said. She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.' As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical. Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population. With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
4 days ago
- Zawya
Taiwan Excellence launches Innovative 'Go Healthy with Taiwan' Campaign in the GCC
Dubai, UAE: In a pioneering effort to boost Taiwan's presence on the global health stage, the International Trade Administration (TITA) under the Ministry of Economic Affairs (MOEA) has launched a worldwide call for proposals. Led by the Taiwan External Trade Development Council (TAITRA), this forward-thinking initiative is driven by the theme – 'Go Healthy with Taiwan'. The campaign aims to showcase Taiwan as a hub of health innovation and provide a catalyst for international collaboration with impactful local implementation. This initiative invites governments, institutions, enterprises, and organisations from across the GCC to submit innovative proposals that seamlessly integrate Taiwan's high-quality health products and holistic solutions. The goal is to collaboratively improve global health standards and enhance well-being across cities, communities, and business ecosystems worldwide. The 'Go Healthy with Taiwan' campaign spotlights five key sectors of Taiwan's health industry: smart healthcare technologies; medical aesthetics and wellness checkups; fitness equipment; sports technologies; and bicycles. Renowned as the 'Bicycle Kingdom', Taiwan is home to a robust and integrated bicycle industry that's powered by leading R&D capabilities. As a global hub for high-end bicycle manufacturing, the country is also driving the transition toward net-zero emissions and playing a pivotal role in international sustainable supply chains. Building on the success of last year's 'Go Green with Taiwan' campaign, which garnered 396 submissions from 45 countries, the new 'Go Healthy with Taiwan' initiative aims to further expand the global impact and practical applications of Taiwan's health industry. This year, the goal is to exceed 500 submissions from across five continents. The top three proposals will each receive a $30,000 award, with all exceptional entries given the opportunity to explore collaboration and commercialisation with leading Taiwanese companies. Furthermore, Taiwanese companies are among the world's top suppliers of fitness equipment – setting international benchmarks through the integration of AI technologies and supported by a strong manufacturing and R&D ecosystem. In the smart healthcare field, Taiwan leverages its world-class ICT and semiconductor expertise in combination with its advanced medical system to deliver comprehensive and integrated solutions for the global health tech market. The submission window, which opened on May 15, will accept proposals until August 14 – offering innovators a prime opportunity to submit their most interesting proposals. At the official launch of the campaign in June, TITA Deputy Director General Susan Hu highlighted President Lai Ching-te's ongoing commitment to advancing the vision of a 'Healthy Taiwan'. The campaign's launch represents a pivotal moment in turning this vision into reality by inviting global innovators to participate and collaborate in shaping a healthier and more sustainable future for all. Joe Chou, Executive Vice President of TAITRA, emphasised that this international call not only highlights the strength and innovation of Taiwan's comprehensive health industry but also encourages collaboration with global partners. It aims to help develop smart and sustainable healthy lifestyles through use of Taiwan's cutting-edge technologies and solutions. The event also unveiled the campaign's vibrant promotional theme, 'Pitching Taiwan's Best: A Home Run for Proposals!' The launch venue was transformed into a baseball field setting to symbolise Taiwan's energetic and proactive international engagement. Taiwanese baseball star An-Ko Lin, celebrated for his standout performance in the WBSC Premier12 tournament, made a surprise appearance alongside "Fu Bear", the mascot of Taiwan Excellence. Their symbolic home runs at the event represented Taiwan's determination to deliver its top-tier health solutions to the global stage while connecting with international innovators. The press conference was also graced by the presence of distinguished guests, including Robert Wu, Chairman of the Taiwan Bicycle Association; Jeff Chen, President of the Taiwan Sporting Goods Manufacturers Association; and Spark Huang, Director of Taiwan Medical and Biotech Industry Association, along with representatives from other key industry sectors. Additionally, media representatives from 12 international outlets spanning across Europe, the US, Southeast Asia, Middle East, and members of the foreign diplomatic corps in Taiwan also attended the event.
